Trial of CPX-351 in Newly Diagnosed Elderly AML Patients
Status:
Completed
Trial end date:
2011-12-01
Target enrollment:
Participant gender:
Summary
The study investigates if CPX-351 will be a) more effective than the standard AML treatment
and b) more tolerable than the standard AML treatment regimens.
The study compares the investigational product CPX-351 vs the standard treatment for AML in
this patients age group.